Successful treatment of a case of COVID-19 pneumonia following kidney transplantation using paxlovid and tocilizumab  

作　　者：Qian Chen Yu-Lin Niu 

机构地区：[1]Department of Organ Transplantation,Affiliated Hospital of Guizhou Medical University,Guiyang 550000,Guizhou Province,China

出　　处：《World Journal of Clinical Cases》2023年第25期6012-6018,共7页世界临床病例杂志

基　　金：Supported by Guiyang Science and Technology Program,No.2019-9-1-39.

摘　　要：BACKGROUND Since its initial detection in 2019,coronavirus disease 2019(COVID-19)pneumonia has rapidly spread throughout the world in a global pandemic.However,reports of COVID-19 pneumonia among patients following kidney transplantation have been limited and no uniform treatment guidelines for these patients have yet to be established.CASE SUMMARY Here,we report the case of a 39-year-old patient recovering from kidney transplantation who contracted perioperative COVID-19 pneumonia that was successfully controlled with oral paxlovid and a single intravenous drip infusion of tocilizumab following the discontinuation of immunosuppressive drugs.CONCLUSION Given the rapid spread of severe acute respiratory syndrome coronavirus 2 infections,clinicians should be aware of the potential for more cases of COVID-19 among patients following kidney transplantation and be familiar with appropriate treatment options and likely clinical outcomes.

关 键 词：Clinical research Kidney transplantation Coronavirus disease 2019 pneumonia Paxlovid TOCILIZUMAB Case report 

分 类 号：R737.31[医药卫生—肿瘤]